Clinical Trials Browser

OTHER × Neoplasms × anlotinib × Clear all

Neoplasms

NCT03736837 2021-03-15

ALTER-L004

Phase 2 Completed

60 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT04566952 2020-10-30

Carcinoma, Ovarian Epithelial, Adnexal Diseases, Carcinoma, Genital Diseases, Female, Genital Neoplasms, Female, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Urogenital Neoplasms

Clinical Trials

Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC

ALTER-L004

ANLOLA